HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hatef Darabi Selected Research

Androgens

6/2011Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.
7/2010Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hatef Darabi Research Topics

Disease

30Breast Neoplasms (Breast Cancer)
12/2017 - 01/2008
16Neoplasms (Cancer)
11/2016 - 07/2010
5Endometrial Neoplasms (Endometrial Cancer)
02/2016 - 07/2010
2Genetic Risk Score
01/2016 - 05/2015
2Lymphoma (Lymphomas)
10/2014 - 01/2013
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2013 - 01/2013
1Brain Neoplasms (Brain Tumor)
12/2019
1Calcinosis
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
02/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Hypersensitivity (Allergy)
11/2015
1Familial Breast Cancer
02/2015
1Rheumatoid Arthritis
07/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2013
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2012
1Carcinogenesis
01/2011

Drug/Important Bio-Agent (IBA)

19Estrogen ReceptorsIBA
12/2017 - 01/2010
8Hormones (Hormone)IBA
02/2016 - 07/2010
5Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2011
5Estrogens (Estrogen)FDA Link
10/2015 - 07/2010
3DNA (Deoxyribonucleic Acid)IBA
12/2019 - 01/2011
3Biological ProductsIBA
12/2017 - 11/2015
33' Untranslated Regions (3' UTR)IBA
01/2016 - 01/2014
3Genetic Markers (Genetic Marker)IBA
01/2016 - 01/2010
2MicroRNAs (MicroRNA)IBA
01/2016 - 01/2014
2ChromatinIBA
01/2016 - 01/2015
2AndrogensIBA
06/2011 - 07/2010
1Biomarkers (Surrogate Marker)IBA
11/2016
1Cadherins (E-Cadherin)IBA
10/2016
1Phenobarbital (Luminal)FDA Link
10/2016
1Codon (Codons)IBA
02/2016
1Estradiol (Delestrogen)FDA LinkGeneric
02/2016
1NucleotidesIBA
01/2016
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2016
1Transforming Growth Factor-beta Type II ReceptorIBA
01/2016
1Interleukin-5 (Interleukin 5)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1Death Domain ReceptorsIBA
01/2016
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2015
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2015
1Deoxyribonuclease I (Nickase)IBA
11/2015
1Transcription Factors (Transcription Factor)IBA
11/2015
1LuciferasesIBA
07/2015
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
07/2015
1cytidylyl-(3'-5')-cytidine (CpC)IBA
02/2015
1Interleukin-8 (Interleukin 8)IBA
10/2014
1mahuang-tangIBA
12/2013
1HLA-DR Antigens (HLA-DR)IBA
07/2013
1Amino AcidsFDA Link
07/2013
1HLA-DRB1 Chains (HLA DRB1)IBA
07/2013
1AntigensIBA
07/2013
1N-acetyltransferase 1IBA
01/2013
1AcetyltransferasesIBA
01/2013
1EnzymesIBA
01/2013
1CarcinogensIBA
01/2013
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2012
1coactivator-associated arginine methyltransferase 1IBA
01/2012
1Progesterone Receptors (Progesterone Receptor)IBA
02/2011
1Tumor Biomarkers (Tumor Markers)IBA
02/2011
1P-2 (P 2)IBA
02/2011
1Aromatase (CYP19)IBA
01/2011
1Indicators and Reagents (Reagents)IBA
01/2010
1Epidermal Growth Factor (EGF)IBA
01/2008

Therapy/Procedure

2Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2017 - 12/2013
1Therapeutics
12/2013